Calidi Biotherapeutics Inc.
About Calidi Biotherapeutics Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Underwritten Public Offering T: - FT: Underwritten Public Offering |
A: 6900000 MR: - FA: 6.9 million FAN: 6900000 |
D: 2025-08-21 FD: 2025-08-21 |
2 investors |
| 2 |
RT: Underwritten Public Offering T: - FT: Underwritten Public Offering |
A: 6000000 MR: - FA: $6 million FAN: 6000000 |
D: 2025-08-20 FD: 2025-08-20 |
2 investors |
| 3 |
RT: Warrant Exercise T: - FT: Warrant Exercise |
A: 4600000 MR: - FA: approximately $4.6 million FAN: 4600000 |
D: 2025-07-09 FD: 2025-07-09 |
- |
| 4 |
RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement |
A: 3900000 MR: - FA: 3.9 million FAN: 3900000 |
D: 2025-03-31 FD: 2025-03-31 |
1 investors |
| 5 |
RT: Registered Direct Offering and Concurrent Private Placement T: - FT: Registered Direct Offering and Concurrent Private Placement |
A: 3900000 MR: - FA: $3.9 million FAN: 3900000 |
D: 2025-03-28 FD: 2025-03-28 |
1 investors |
| 6 |
RT: Public Offering T: - FT: Public Offering |
A: 4250000 MR: - FA: approximately $4.25 million FAN: 4250000 |
D: 2025-01-10 FD: 2025-01-10 |
- |
| 7 |
RT: Public Offering T: - FT: Public Offering |
A: 7500000 MR: - FA: 7.5 million FAN: 7500000 |
D: 2024-11-15 FD: 2024-11-15 |
- |
| 8 |
RT: Public Offering T: - FT: Public Offering |
A: 7500000 MR: - FA: 7.5 million FAN: 7500000 |
D: 2024-11-14 FD: 2024-11-14 |
- |
| 9 |
RT: Registered Direct Offering and Concurrent Private Placement T: - FT: Registered Direct Offering and Concurrent Private Placement |
A: 2000000 MR: - FA: Approximately $2 million FAN: 2000000 |
D: 2024-10-23 FD: 2024-10-23 |
1 investors |
| 10 |
RT: Warrant Exercise T: - FT: Warrant Exercise |
A: 2100000 MR: - FA: 2.1 million FAN: 2100000 |
D: 2024-05-31 FD: 2024-05-31 |
- |
| 11 |
RT: Public Offering T: - FT: Public Offering |
A: 6100000 MR: - FA: 6.1 million FAN: 6100000 |
D: 2024-04-19 FD: 2024-04-19 |
1 investors |
| 12 |
RT: Public Offering T: - FT: Public Offering |
A: 6100000 MR: - FA: approximately $6.1 million FAN: 6100000 |
D: 2024-04-16 FD: 2024-04-16 |
- |
| 13 |
RT: Grant T: - FT: Grant |
A: 5300000 MR: - FA: $5.3 million FAN: 5300000 |
D: 2024-03-11 FD: 2024-03-11 |
1 investors |
| 14 |
RT: Series B T: - FT: Series B |
A: 25000000 MR: - FA: $25 million FAN: 25000000 |
D: 2023-06-23 FD: 2023-06-23 |
2 investors |
Growth Metrics
Team & Leadership
Eric Poma
Chief Executive Officer and board director
Andrew Jackson
Financial Executive
Antonio F. Santidrian
Chief Scientific Officer
Guy Travis Clifton
Chief Medical Officer
Boris Minev
Physician-Scientist
Wendy Pizarro
Chief Legal Officer and Chief Diversity Officer
Recent News
Calidi Biotherapeutics Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- calidibio.com
- Industries
- Biotechnology / Healthcare
- Company Size
- ~460 employees (est.)
- Locations
- San Diego, California
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro